ADALIMUMAB FOSIMDESONIDE
UNII FWC6IWT3EH

Substance Identification & Data

This profile provides standardized clinical and technical data for Adalimumab Fosimdesonide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FWC6IWT3EH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2402772-93-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FWC6IWT3EH
CAS Registry Number
2402772-93-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ADALIMUMAB FOSIMDESONIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C190447
National Cancer Institute reference terminology for clinical and research data.
INN ID
11661
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
LM-233
Identifier assigned by the United States Adopted Names Council.
Substance Type
Adalimumab Fosimdesonide
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Adalimumab Fosimdesonide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Adalimumab Fosimdesonide

Common Names & Synonyms

ABBV 154 [WHO-DD]
ADALIMUMAB FOSIMDESONIDE [USAN]
Immunoglobulin G1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain), complex with human monoclonal D2E7 light chain, dimer, 214′′,214′′′,224,224′-tetrakis(thioether) with N-(2-mercaptoacetyl)glycyl-N-[3-[[4-[(R)-[[(11β,16α)-11-hydroxy-3,20-dioxo-21-(phosphonooxy)pregna-1,4-diene-16,17-diyl]bis(oxy)]methyl]phenyl]methyl]phenyl]-L-α-glutamine
adalimumab fosimdesonide [INN]
gamma1 heavy chain Homo sapiens (1-450) [VH(Homo sapiens IGHV3-9*01 (93.9%) -(IGHD) -IGHJ4*01 (92.9%)) CDR-IMGT [8.8.14] (26-33.51-58.97-110) (1-121) -Homo sapiens IGHG1*01 (100%)G1m17,1 (CH1 K120 (218) (122-219), hinge 1-15(220-234), CH2 (235-344), CH3 D12 (360), L14 (362)(345-449), CHS K>del (450)) (122-450)], (224-214')-disulfide with kappa light chain Homo sapiens (1'-214')[V-KAPPA (Homo sapiens IGKV1-27*01 (95.8%) -IGKJ2*01 (91.7%) L124>V (104)) CDR-IMGT [6.3.9] (27-32.50-52.89-97) (1'-107') -Homo sapiens IGKC*01(100%) Km3 A45.1 (153), V101 (191) (108'-214')], dimer (230-230'':233-233'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1, glycoform alfa; conjugated at the S atoms of the reduced cysteinyl 224, 214', 224'' and 214''' with four 2-{[2-({(2S)-4-carboxy-1-[4-({4-[11β-hydroxy-3,20-dioxo-21-(phosphonooxy)-2'H,16βH-[1,3]dioxolo[4',5':16,17]pregna-1,4-dien-2'α-yl]phenyl}methyl)anilino]-1-oxobutan-2-yl}amino)-2-oxoethyl]amino}-2-oxoethyl (fosimdesonide) groups
immunoglobulin G1-kappa, anti-[Homo sapiens TNF (tumor necrosis factor (TNF) superfamily member 2, TNFSF2, TNF-alpha, TNFA)], Homo sapiens monoclonal antibody, conjugated to a derivative of the glucocorticoid receptor modulator (GRM) desonide (24)(12) via a (cystein-S-yl)acetyl-Gly-Glu link

Technical Codes

ABBV-154
ABBV154

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus